ReviewTherapeutic advances in respiratory disease

Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.

Lindsay Somerville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.